Dariohealth Corp Stock Alpha and Beta Analysis
| DRIO Stock | USD 0.79 0.07 9.72% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as DarioHealth Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in DarioHealth Corp over a specified time horizon. Remember, high DarioHealth Corp's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to DarioHealth Corp's market risk premium analysis include:
Beta 1.89 | Alpha (0.17) | Risk 5.33 | Sharpe Ratio 0.0115 | Expected Return 0.0615 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
DarioHealth |
DarioHealth Corp Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. DarioHealth Corp market risk premium is the additional return an investor will receive from holding DarioHealth Corp long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in DarioHealth Corp. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate DarioHealth Corp's performance over market.| α | -0.17 | β | 1.89 |
DarioHealth Corp expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of DarioHealth Corp's Buy-and-hold return. Our buy-and-hold chart shows how DarioHealth Corp performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.DarioHealth Corp Market Price Analysis
Market price analysis indicators help investors to evaluate how DarioHealth Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading DarioHealth Corp shares will generate the highest return on investment. By understating and applying DarioHealth Corp stock market price indicators, traders can identify DarioHealth Corp position entry and exit signals to maximize returns.
DarioHealth Corp Return and Market Media
The median price of DarioHealth Corp for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 is 0.93 with a coefficient of variation of 11.36. The daily time series for the period is distributed with a sample standard deviation of 0.1, arithmetic mean of 0.92, and mean deviation of 0.09. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8401 subject to Rule 16b-3 | 09/06/2024 |
2 | Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8 subject to Rule 16b-3 | 09/09/2024 |
3 | Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8045 subject to Rule 16b-3 | 09/11/2024 |
4 | TinyGemsBreaks DarioHealth Corp. Expands Cardiometabolic Health Solution with Twill Behavioral Health Integration for Enhanced Member Engagement | 09/12/2024 |
5 | DRIO - DarioHealth Corp. Latest Stock News Market Updates - StockTitan | 09/17/2024 |
6 | National Medicare Health Plan Partners with Twill by Dario to Promote Healthy Aging with New Digital Mental Health Benefits for Seniors | 10/01/2024 |
7 | A Piece Of The Puzzle Missing From DarioHealth Corp.s 27 percent Share Price Climb | 10/03/2024 |
8 | Dario Announces Complete Integration of Twill Capabilities Across Full Multi-Condition Platform | 10/17/2024 |
9 | Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8442 subject to Rule 16b-3 | 11/01/2024 |
10 | DarioHealth Set to Announce Quarterly Earnings on Thursday | 11/06/2024 |
11 | DarioHealth Reports Third Quarter 2024 Financial and Operating Results | 11/07/2024 |
12 | DarioHealth Corp. Q3 2024 Earnings Call Transcript | 11/11/2024 |
13 | Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.9092 subject to Rule 16b-3 | 11/12/2024 |
14 | Dario Signs Four New Employer Contracts Across Full Product Suite | 11/21/2024 |
About DarioHealth Corp Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including DarioHealth or other stocks. Alpha measures the amount that position in DarioHealth Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 3.24 | 7.75 | 12.7 | 13.34 | Days Of Inventory On Hand | 137.35 | 161.32 | 128.59 | 93.0 |
DarioHealth Corp Upcoming Company Events
As portrayed in its financial statements, the presentation of DarioHealth Corp's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DarioHealth Corp's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of DarioHealth Corp's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of DarioHealth Corp. Please utilize our Beneish M Score to check the likelihood of DarioHealth Corp's management manipulating its earnings.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with DarioHealth Corp
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out DarioHealth Corp Backtesting, DarioHealth Corp Valuation, DarioHealth Corp Correlation, DarioHealth Corp Hype Analysis, DarioHealth Corp Volatility, DarioHealth Corp History and analyze DarioHealth Corp Performance. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
DarioHealth Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.